Precision Health Clinical Trials
A Phase 1 Trial of the p97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Advanced Solid Tumors; Advanced Lymphomas
Intervention: Drug: CB-5339
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
Intervention: Drug: CB-5339
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
For more information, visit the Study URL.
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Condition: Neoplasms
Interventions: Drug: Nilotinib; Drug: Paclitaxel
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
Interventions: Drug: Nilotinib; Drug: Paclitaxel
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
For more information, visit the Study URL.
Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)
Condition: Pancreas Adenocarcinoma
Interventions: Genetic: Analysis of genetic mutations and the gene expression profile of lung metastasis and primary neoplasia; Other: Radiomics analysis on TAC imaging at diagnosis of lung metastasis and, if possible, of the primary tumor
Sponsor: IRCCS San Raffaele
Recruiting
Interventions: Genetic: Analysis of genetic mutations and the gene expression profile of lung metastasis and primary neoplasia; Other: Radiomics analysis on TAC imaging at diagnosis of lung metastasis and, if possible, of the primary tumor
Sponsor: IRCCS San Raffaele
Recruiting
For more information, visit the Study URL.
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Condition: Uveal Melanoma
Intervention: Other: Blood test
Sponsor: Institut Curie
Recruiting
Intervention: Other: Blood test
Sponsor: Institut Curie
Recruiting
For more information, visit the Study URL.
ImmuneSense Lyme Study
Condition: Lyme Disease
Intervention: Diagnostic Test: T-Detect Lyme
Sponsors: Adaptive Biotechnologies; Iqvia Pty Ltd
Recruiting
Intervention: Diagnostic Test: T-Detect Lyme
Sponsors: Adaptive Biotechnologies; Iqvia Pty Ltd
Recruiting
For more information, visit the Study URL.
Histological, Genetic and Epigenetic Analysis of Procedures Related With Dental Implants
Conditions: Peri-Implantitis; Peri-implant Mucositis; Implant Complication; Implant Tissue Failure
Interventions: Procedure: Gingival and bone sample collection; Procedure: Healthy individuals
Sponsors: Simón Pardiñas López; NYU Langone Health; Göteborg University; University Hospital A Coruña; Instituto de Investigacion Biomedica de A Coruna
Recruiting
Interventions: Procedure: Gingival and bone sample collection; Procedure: Healthy individuals
Sponsors: Simón Pardiñas López; NYU Langone Health; Göteborg University; University Hospital A Coruña; Instituto de Investigacion Biomedica de A Coruna
Recruiting
For more information, visit the Study URL.
Epigenetic Tools as Prognostic Predictors in Covid19
Condition: Prognosis
Intervention: Other: Taking biological samples
Sponsors: Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Istanbul University
Recruiting
Intervention: Other: Taking biological samples
Sponsors: Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Istanbul University
Recruiting
For more information, visit the Study URL.
Determining the Reproductive Health of Men Post-COVID-19 Infection
Conditions: Infertility, Male; Testosterone Deficiency
Intervention: Other: Exposure: Covid-19 infection
Sponsor: Imperial College London
Not yet recruiting
Intervention: Other: Exposure: Covid-19 infection
Sponsor: Imperial College London
Not yet recruiting
For more information, visit the Study URL.
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
Condition: Sickle Cell Disease
Intervention:
Sponsors: St. Jude Children's Research Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
Intervention:
Sponsors: St. Jude Children's Research Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
For more information, visit the Study URL.
Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients
Condition: Bladder Cancer
Intervention:
Sponsors: Hopital Foch; AstraZeneca
Recruiting
Intervention:
Sponsors: Hopital Foch; AstraZeneca
Recruiting
For more information, visit the Study URL.